Browse drugs

…duals at borderline or intermediate risk of ASCVD.16 Similarly, FIB-4 may serve an analogous role in nephrology by identifying patien…

…nents are measured at different time intervals, suggesting that FIB-4 can still be readily used even when not all components are avai…

…Background Oestrogen is hepatoprotective, yet sex-specific fibrosis risk architectur…

…y a LSM >8kPa) that would have been missed if relying solely on FIB-4.Among patients with F2-F4 fibrosis, 32% had low FIB-4 scores, a…

…ilar performance to FIB-4 so may offer a simpler alternative to FIB-4 as a tool to identify patients at high risk of cACLD.Abstract O…

…rity<0.001 for KDIGO 3–4; p=0.010 for CKD).Conclusions Elevated FIB-4 is independently associated with KDIGO 3–4 and CKD, and identif…

…ups, with critical underdetection in NH Asian adults harbouring insulin- and inflammation-mediated fibrosis pathways invisible to BMI-c…

… results for patients who followed the pathway as per protocol. FIB-4 testing demonstrated reduced sensitivity in individuals with T2…

…ACLD in primary care.Abstract FP26 Figure 1(A) ELF Pathway; (B) FIB-4 AND ELF; (C) GGT AND ELF. Abbreviations: TP: true positive; TN:…

…IB-4 <1.3.Conclusions Given the limitations of biopsy NITs like FIB-4 may be used to assess disease severity and disease progression.…

…000/QALY). In our decision set, the cheapest strategy is to use FIB-4 in the reactive-only population; however, this misses 43.6% of …

…cy, with a sensitivity of 70% and specificity of 68%. Combining FIB-4 and APRI improved overall predictive value, reducing the need f…